🇺🇸 FDA
Patent

US 9499497

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

granted A61KA61K31/4192A61K31/4439

Quick answer

US patent 9499497 (Compounds useful as inhibitors of indoleamine 2,3-dioxygenase) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/4192, A61K31/4439, A61K45/06, A61P